|
|
|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
| PolysacDB ID | 1633 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab A1E |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid but cross-reacted with Mycobacterium terrae. Mycobacterium nonchromogenicum and Mycobacterium fortuitium |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1634 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1635 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab A2A |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1636 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab A3H |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1637 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B2G |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1638 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B5B |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1639 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B5H |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1640 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B8F |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1641 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B9D |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab cross-reacted with M. kansasii phenolic glycolipid and cross-reacted with whole cells of 20 mycobacterial strains |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 26-09-2010 |
| References | PMC263407 |
| PolysacDB ID | 1642 |
| Carbohydrate Name | Phenolic glycolipid antigen (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | It consisting of terminal 3,6-di-O-methyl glucose linked β1-->4 to 2,3-di-O-methyl rhamnose, which in turn is linked α1-->2 to 3-O-methyl rhamnose |
| BCSDB Structure | 114263 |
| Proposed Function | It has been proposed to protect pathogenic mycobacteria such as Mycobacterium lepraemurium from the host bactericidal activities in phagocytic cells |
| Antigenic Nature | Partially purified phenolic glycolipid from M. leprae |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab B1OH |
| Antibody Type Class | IgM |
| Assay System | ELISA, TLC autoradiography and immunofluorescence |
| Cross Reactivity | This Mab was specific to M. leprae glycolipid |
| Proposed Epitope | Terminal 3,6-di-O-methyl glucose residues were proposed to be a part of the epitope |
| IEDB Epitope | 76895 |
| Proposed Utility | This Mab may provide more information on the structure of phenolic glycolipid of M. leprae and the localization of this antigen can be performed within infected lesions by immunofluorescence |
| Curator ID | AA + AS |
| Date of Curation | 27-09-2010 |
| References | PMC263407 |
|
Department of Computational Biology, Indraprastha Institute of Information Technology, Sec - 39A, New Delhi, India - 110020 |